Skip to content

Direct Access Physiotherapy in the Pediatric Emergency Department

Improving Access to Quality Care for Children and Adolescents Presenting to the Pediatric Emergency Department With Musculoskeletal Problems: a Pilot Randomized Control Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06069011
Acronym
PedEDmsk
Enrollment
66
Registered
2023-10-05
Start date
2023-09-18
Completion date
2023-12-31
Last updated
2024-04-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Musculoskeletal Diseases or Conditions, Musculoskeletal Pain

Brief summary

The goal of this clinical trial is to compare two methods of managing low acuity musculoskeletal complaints in children and adolescents ages 6 to 17.99 years in the pediatric emergency department. The main question it aims to answer is whether delivering care in two methods is feasible. Participants will receive care while in the emergency department and will be followed for a period of 1-month post-presentation.

Interventions

assessment and treatment in an interdisciplinary model

OTHERusual care

assessment and treatment in usual care model

Sponsors

McGill University Health Centre/Research Institute of the McGill University Health Centre
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
6 Years to 17 Years
Healthy volunteers
No

Inclusion criteria

* aged 6.00-17.99 years of age * present to the Montreal Children's Hospital Emergency Department with a suspected MSK complaint, traumatic or not * are given a triage score of 3 (urgent), 4 (less urgent), or 5 (nonurgent) according to the Canadian Triage and Acuity Scale (CTAS) * are able to communicate in French or English

Exclusion criteria

* present with a major MSK condition requiring urgent care (e.g., open fracture, open wound) * a red flag (e.g. progressive neurological disorder, infectious symptoms) * a co-morbid unstable condition.

Design outcomes

Primary

MeasureTime frameDescription
Rate of consentthrough study completion an average of 4 weeks post-enrolmentrate of consented patients related to patients approached rate of randomization, feasibility of administration of outcomes
Completed outcome measuresthrough study completion an average of 4 weeks post-enrolmentproportion of participants who complete all outcome measures

Secondary

MeasureTime frameDescription
Pain intensity on faces rating scalethrough study completion an average of 4 weeks post-enrolmentPain intensity on faces rating scale, scale from 0 to 10, with 10 being a worse score
Pain interference with function PROMIS scalethrough study completion an average of 4 weeks post-enrolmentPROMIS Pediatric Pain Interference - Short Form 8a, 8 items scores from 1-5 with 5 being a worse outcome

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026